CIK 0001771706 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vireo Growth Inc.
Sign in to watch- Ticker
- VREOF
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 612-999-1606
- Business address
- 207 SOUTH 9TH STREET, MINNEAPOLIS, MN, 55402
- Former names
- Goodness Growth Holdings, Inc., Vireo Health International, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-17 | Nordquist Judd Theodore Director | Grant or award · Stock options (right to buy) | +53,052 | 53,052 | ||
| 2025-01-17 | Nordquist Judd Theodore Director | Grant or award · Restricted stock units | +44,643 | 44,643 | ||
| 2025-01-17 | Mancebo Victor E. Director | Grant or award · Stock options (right to buy) | +53,052 | 53,052 | ||
| 2025-01-17 | Mancebo Victor E. Director | Grant or award · Restricted stock units | +44,643 | 44,643 | ||
| 2025-01-17 | Hussey Ross Michael Director | Grant or award · Stock options (right to buy) | +53,052 | 53,052 | ||
| 2025-01-17 | Hussey Ross Michael Director | Grant or award · Restricted stock units | +44,643 | 44,643 | ||
| 2024-12-30 | Chicago Atlantic Credit Opportunities, LLC 10% owner | Purchase | +32,032,000 | $0.63 | $20.0M | 110,362,683 |
| 2024-12-17 | Macdonald Tyson Chief Financial Officer | Grant or award | +3,200,000 | 3,200,000 | ||
| 2024-12-17 | Macdonald Tyson Chief Financial Officer | Shares withheld for taxes | −360,000 | $0.25 | $90K | 2,840,000 |
| 2024-12-17 | Macdonald Tyson Chief Financial Officer | Grant or award | +3,200,000 | 3,200,000 | ||
| 2024-12-17 | Kingsley Kyle Eugene Co-Executive Chairman | Grant or award | +7,000,000 | 13,541,100 | ||
| 2024-12-17 | Mazarakis John Chief Executive Officer | Grant or award | +3,200,000 | 3,200,000 | ||
| 2024-11-01 | Chicago Atlantic Credit Opportunities, LLC 10% owner | Purchase · Convertible Note (right to buy) | +0 | $10,000,000.00 | $0 | |
| 2024-10-10 | Shimpa Amber Holly CEO and President | Grant or award · Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2024-10-10 | Rosen Joshua CEO and Interim CFO | Grant or award | +500,000 | 500,000 | ||
| 2024-10-09 | Rosen Joshua CEO and Interim CFO | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2024-08-23 | Rosen Joshua See Remarks | Grant or award · Stock Option (right to buy) | +160,162 | 160,162 | ||
| 2024-08-23 | Rosen Joshua See Remarks | Grant or award · Restricted stock units | +134,195 | 134,195 | ||
| 2024-08-23 | Rosen Joshua See Remarks | Grant or award · Restricted stock units | +216,450 | 216,450 | ||
| 2024-08-23 | Nordquist Judd Theodore Director | Grant or award · Stock options (right to buy) | +499,559 | 499,559 |
Page 5 of 9 · 171 trades